Autonomix Medical, Inc.
AMIX
$1.39
-$0.05-3.47%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 26.89% | 79.28% | 292.17% | 360.05% | 321.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 55.02% | 88.10% | 227.61% | 279.41% | 275.74% |
| Operating Income | -55.02% | -88.10% | -227.61% | -279.41% | -275.74% |
| Income Before Tax | 26.04% | -27.64% | -73.04% | -601.57% | -675.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 26.04% | -27.64% | -73.04% | -601.57% | -675.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.04% | -27.64% | -73.04% | -601.57% | -675.41% |
| EBIT | -55.02% | -88.10% | -227.61% | -279.41% | -275.74% |
| EBITDA | -115.91% | -262.98% | -- | -- | -- |
| EPS Basic | 55.46% | 19.91% | -7.64% | -384.75% | -439.49% |
| Normalized Basic EPS | 55.46% | 19.91% | -7.64% | -384.75% | -439.49% |
| EPS Diluted | 55.46% | 19.91% | -7.64% | -384.75% | -439.49% |
| Normalized Diluted EPS | 55.46% | 19.91% | -7.64% | -384.75% | -439.49% |
| Average Basic Shares Outstanding | 90.53% | 72.76% | 67.92% | 55.58% | 45.93% |
| Average Diluted Shares Outstanding | 90.53% | 72.76% | 67.92% | 55.58% | 45.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |